Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 03, 2019

SELL
$45.92 - $67.67 $162,143 - $238,942
-3,531 Closed
0 $0
Q4 2018

Feb 12, 2019

SELL
$42.73 - $76.53 $3,888 - $6,964
-91 Reduced 2.51%
3,531 $163,000
Q3 2018

Nov 05, 2018

BUY
$71.67 - $91.95 $37,268 - $47,814
520 Added 16.76%
3,622 $279,000
Q1 2018

May 03, 2018

SELL
$59.83 - $86.53 $5,863 - $8,479
-98 Reduced 3.06%
3,102 $254,000
Q4 2017

Feb 07, 2018

SELL
$52.12 - $72.33 $31,272 - $43,398
-600 Reduced 15.79%
3,200 $183,000
Q3 2017

Nov 06, 2017

BUY
$54.89 - $67.12 $208,582 - $255,056
3,800
3,800 $254,000

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.05B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track C World Wide Group Holding A Portfolio

Follow C World Wide Group Holding A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

News

Stay updated on C World Wide Group Holding A with notifications on news.